Private Equity Bigwigs Buy Biomet

Dec 20 2006 | 12:42pm ET

A consortium of private equity heavyweights has agreed to pay $10.9 billion for medical device manufacturer Biomet.

The group includes the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and Texas Pacific Group.

Warsaw, Ind.-based Biomet designs and manufactures musculoskeletal medical products. The deal, which offers $44 per share and was unanimously approved by Biomet’s board, awaits shareholder approval.


In Depth

Don’t Overlook These 6 Hybrid Cloud Concerns

Sep 14 2017 | 6:27pm ET

Cloud-based technology solutions have made tremendous inroads into the alternative...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Cash: An Asset In Adolescence

Aug 31 2017 | 3:34pm ET

If the investment industry has a rebellious teenager in the house today, that teenager...

 

From the current issue of